Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
about
Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist PerspectiveBehavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADThe role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target?Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 miceAlzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking.Wnt signaling in the nervous system and in Alzheimer's disease.Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication.Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins.Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?Nicotine contributes to the neural stem cells fate against toxicity of microglial-derived factors induced by Aβ via the Wnt/β-catenin pathway.Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation.Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice.Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.Phosphoinositides: Two-Path Signaling in Neuronal Response to Oligomeric Amyloid β Peptide.
P2860
Q26774441-AE267F6E-D698-411B-9F9A-0E1D76BB9016Q26858963-82C3DC54-4843-455C-9081-7E4FC5D4D012Q28547449-307103A7-7D17-49E8-8A49-8EE50FE23677Q33634629-9885A075-8DEF-4C65-89C4-2F95824F172BQ33938047-1CFD2653-7BF2-44F7-8D06-F3052F2873ACQ33959032-C61D2FAA-CE51-4205-969F-24C51863DD8AQ36959844-9CE7DEBF-855C-4616-8F13-854B334C7332Q38189240-0AF1390A-A6BB-439E-A5B7-466FBA670CA6Q38253573-F4C02F53-59E1-4961-A322-4BA3809159D2Q38286246-B2ED3DDF-A8CC-45DE-93CB-FE6D217BA9F1Q38888246-D324220A-B1A0-4D6D-B31C-3AC6541787BFQ38962792-FFBC344D-CD2B-4284-9D81-CEBE0E253F8FQ40911238-77EABBD1-958C-4FC8-A578-3E587C613A3CQ47095504-106D819D-EF0C-41CA-AFFD-9C6C0F2B386DQ47098610-F3C9966C-E90D-42F9-B4DB-D08BF0F92821Q48284096-AFB26726-6419-4F42-88AD-005B5C7E68F8Q53121718-69C26FE7-7EAE-4F43-BA5F-F3A05509D785
P2860
Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Nicotine prevents synaptic imp ...... ylcholine receptor activation.
@en
Nicotine prevents synaptic imp ...... ylcholine receptor activation.
@nl
type
label
Nicotine prevents synaptic imp ...... ylcholine receptor activation.
@en
Nicotine prevents synaptic imp ...... ylcholine receptor activation.
@nl
prefLabel
Nicotine prevents synaptic imp ...... ylcholine receptor activation.
@en
Nicotine prevents synaptic imp ...... ylcholine receptor activation.
@nl
P2093
P2860
P1476
Nicotine prevents synaptic imp ...... tylcholine receptor activation
@en
P2093
Francisco J Carvajal
Ginny G Farias
Jessica Y Vargas
Juvenal A Rios
Macarena S Arrazola
Nibaldo C Inestrosa
P2860
P2888
P304
P356
10.1007/S12017-013-8242-1
P577
2013-07-11T00:00:00Z